The foundation of drug delivery systems based on titanium dioxide nanotube arrays has become an important means to increase the drug release performance of bone implantation materials. However, most of the conventional platforms have some disadvantages, such as large sudden release, uncontrollable, unintelligent, or not on-demand drug release process. Herein, the authors develop a unique self-triggering drug release system (SDDS), utilizing the advantages of 1-Tetradecanol (TD), such as decent biocompatibility, a phase transition temperature of 37.8°C, and the inexistence of complex chemical reaction process. The establishment of the platform can make a large amount of the anti-inflammatory drug (ibuprofen, IBU) released when the body or the affected area is inflamed, that is, when the temperature rises. Conversely, only a small amount or no drug is released when there is no inflammation, thereby achieving self-trigger release and on-demand release. The experimental results show that the system combines good self-trigger release properties, release sensitivity, drug release cycle, and low selectivity to the loaded drugs.
Microbial infections are considered one of the most important concerns of the world community. Developing drug delivery systems based on formulation of nanoparticles (NPs) with antimicrobial agents has shown beneficial effectiveness against microbial infections and related antimicrobial resistance. In this study, the authors prepared and characterized a chitosan-based hydrogel loaded with zinc oxide NPs for controlling the release of vancomycin and also improving its antibacterial effect. Characterization studies demonstrated that the developed biopolymeric hydrogel was able to sustain and control the release of vancomycin in response to acidic media for 96 h. Furthermore, antimicrobial studies showed significant and efficient antibacterial activity of prepared hydrogel against Staphylococcus aureus and Pseudomonas aeruginosa. Based on the obtained results, it can be concluded that the prepared chitosan hydrogel (CH) containing zinc oixde (ZnO) NPs has a desirable activity for controlling the release of vancomycin and improving its antibacterial properties.
The chronic lesion has become a major biological difficulty. Using nanoparticles as drug delivery systems is remarkable nowadays. The unique properties of chitosan in combination with epidermal growth factor (EGF) can accelerate the wound-healing process.
In this study, Chitosan-EGF (CS-EGF) nanoparticles were manipulated and characterized by Transmission Electron Microscopy (TEM) microscopy, dynamic light scattering (DLS) method, and Fourier Transform Infrared Spectroscopy (FTIR) radiation. The antibacterial effect was estimated by minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC) methods and the proliferation assay was measured on the HFF-1 (human fibroblast cell line). Then, migration assay was accomplished and the gene expression analysis for transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and platelets-derived growth factor (PDGF) was manipulated by the real-time-PCR method. The obtained results were considered statistically significant with P < 0.05.
Obtained results illustrated no toxic effect on the HFF-1 cell line treated with CS-EGF. In cellular proliferation and migration assays, CS-EGF nanoparticles demonstrated 2-folds higher than the control. In the duration of 72 h of the experiment, and concentration of 10 µM, 90 ±10% of cells were migrated and the whole scratch was covered by fibroblasts. The real-time-PCR analysis also showed 7.5, 4.5-, and 7-fold upregulation of all TGF-β, VEGF, and PDGF genes in comparison with the control group.
This study confirmed that using chitosan nanoparticles as a carrier for EGF can accelerate cellular remodelling and annihilate bacterial infection in the process of treatment. As CS-EGF nanoparticles in the acceleration of the skin remodelling process showed promising results, subsequent studies might be useful.
The zinc oxide-silver oxide nanocomposite (ZnO.Ag2O3 particles) was prepared by using an aqueous plant extract of Haplophyllum obtusifolium for the first time. Powder X-ray diffraction (PXRD), Fourier transforms spectroscopy (FTIR), field emission microscopy (FESEM), energy dispersive X-ray analysis (EDX), and transmission electron microscopy (TEM) were applied to analyze the structure, functional groups, morphology, and purity of the prepared nanocomposite. PXRD revealed the formulation of ZnO.Ag2O3 for the particles. The investigation of functional groups has demonstrated the presence of some carbonated impurities along with absorbed water in the composition of the ZnO.Ag2O3 nanocomposite. Morphologically, particles have formed a petal-like shape with different sizes. The EDX analysis also confirmed the composition of the prepared sample and the presence of 4.78% silver in the formula. Additionally, the TEM analysis revealed spherical and rectangular shapes with a particle size of 80.43 ± 46.73 nm. Moreover, the ZnO.Ag2O3 particles were used against cancer cells, which has shown synthesized NCs have a toxic effect against liver cancer cells in a concentration and time-dependent manner.